Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,834,154
+$227,727 QoQ
Shares Held
24,465
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#311
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Asset Management, Inc. holds $248,035,659 across 15 Drug Manufacturers - General names. NVS ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
346,193 | $44,485,800 | |
| 2 | AMGN |
Amgen Inc
|
97,240 | $35,212,548 | |
| 3 | JNJ |
Johnson & Johnson
|
137,584 | $34,942,208 | |
| 4 | LLY |
ELI LILLY & Co
|
22,773 | $27,314,621 | |
| 5 | ABBV |
AbbVie Inc.
|
87,496 | $22,017,493 | |
| 6 | PFE |
Pfizer Inc
|
873,428 | $21,032,146 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
302,317 | $17,419,505 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
127,450 | $16,102,033 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,834,154 | 24,465 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,606,427 | 23,610 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,865,352 | 20,783 | Shares | Sole | 2026-08-21 | |
| 2025-09-30 | $2,572,109 | 20,057 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,648,424 | 21,886 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,712,977 | 24,336 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,524,221 | 25,940 | Shares | Sole | 2026-08-21 | |
| 2024-09-30 | $2,844,099 | 24,727 | Shares | Sole | 2026-08-21 | |
| 2024-06-30 | $2,874,845 | 27,004 | Shares | Sole | 2026-08-21 | |
| 2024-03-31 | $2,410,414 | 24,919 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,270,613 | 22,488 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,082,425 | 20,444 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,076,929 | 20,582 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,634,196 | 17,763 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,729,123 | 19,060 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,499,449 | 19,727 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,944,866 | 23,008 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,958,404 | 22,318 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $2,059,831 | 23,549 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,982,837 | 24,246 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,939,258 | 76,055 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $8,909,580 | 104,230 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $12,062,677 | 127,742 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $12,633,983 | 145,285 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,124,626 | 138,821 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $10,945,814 | 132,757 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||